Patient Scenario 3: Treating RR DTC With an Identified RET F

Centering discussion on the final clinical scenario of RR DTC, Francis Worden, MD, highlights the management of a patient with an identified RET rearrangement.

Related Keywords

Francis Worden , , Treatment Approaches , Sequencing Strategies , Differentiated Thyroid Cancer , Thyroid Cancer , Dtc Cancer , Dtc , Ret Fusions , Ret Expression , Lenvatinib , Pembrolizumab , Combination Therapy , Selpercatinib , Ret Inhibitor , Cns , Cns Disease ,